NCT06135415 2026-01-22
TirbAKare
Almirall, S.A.
Phase 3 Completed
Clinical Trials
10 trialsNCT05060237 2024-10-17
Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
Biofrontera Bioscience GmbH
Phase 1 Completed
NCT02844777 2023-01-12
Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis
Vidac Pharma
Phase 2 Completed
NCT03285477 2021-04-13
AK003
Almirall, S.A.
Phase 3 Completed
NCT00103246 2019-01-22
Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00021294 2018-09-11
Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis
University of Arizona
Phase 2 Completed
NCT00099112 2015-04-30
Effect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin of Healthy Adults With Fitzpatrick Skin Type II
National Cancer Institute (NCI)
Completed
NCT00608634 2015-04-01
Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses
University of Arizona
Phase 2 Completed
NCT00002975 2013-10-10
Photodynamic Therapy in Treating Patients With Skin Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT00175643 2006-05-09
Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses
University of British Columbia
Phase 3 Completed